Related Experiment Videos
International collaboration on childhood leukemia
Ching-Hon Pui1, Raul C Ribeiro
1Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA. ching-hon.pui@stjude.org
International Journal of Hematology
|January 6, 2004
Summary
International collaboration significantly improves childhood acute lymphoblastic leukemia (ALL) cure rates. "Twinning" partnerships are most effective for advancing treatment in developing countries.
Area of Science:
- Pediatric Oncology
- Global Health
- Cancer Research
Background:
- Childhood acute lymphoblastic leukemia (ALL) cure rates vary dramatically worldwide, exceeding 80% in industrialized nations but remaining below 10% in developing countries.
- Significant disparities in ALL treatment outcomes necessitate international collaboration to improve survival rates globally.
Purpose of the Study:
- To outline international collaborative strategies aimed at advancing childhood acute lymphoblastic leukemia (ALL) cure rates.
- To identify effective approaches for improving ALL treatment and survival in resource-limited settings.
Main Methods:
- Formation of parallel initiatives involving industrialized and developing countries.
- Data pooling for in-depth studies on high-risk or drug-resistant ALL subgroups in industrialized nations.
- Establishment of alliances between governmental, non-governmental, healthcare, and international organizations.
- "Twinning" partnerships between established institutions and pediatric cancer units in developing countries.
Main Results:
- Industrialized countries focus on biological and heterogeneity studies of high-risk ALL to find novel treatments.
- Alliances are being formed to enhance childhood leukemia survival in developing countries.
- "Twinning" partnerships have emerged as the most successful strategy for improving outcomes in developing nations.
Conclusions:
- International collaboration and strategic partnerships are crucial for global advancements in childhood acute lymphoblastic leukemia (ALL) treatment.
- Targeted initiatives, particularly "twinning" programs, offer a promising model for reducing disparities and improving ALL survival rates in developing countries.